Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Immunotherapy, Tumor Microenvironment and Survival Signaling
| Immunotherapy, Tumor Microenvironment and Survival Signaling |
| Autore | Golubovskaya Vita |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (376 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
angiogenesis
antigen loss Autophagy BCMA breast cancer cancer cancer immunotherapy cancer metabolism cancer nanomedicine cancer stem cells cancer vaccines CAR macrophage CAR T cell CAR-T CAR-T cells cardiotoxicity CD11 CD18 CD19 CD37 cell therapy cell-cell contact check point inhibitors checkpoint chemotherapy chimeric antigen receptor chimeric antigen receptors clonogenicity colorectal cancer combination therapy crosstalk DCLK1 dendritic cells electroporation hypoxia immune checkpoint inhibitor immune checkpoint inhibitors immune escape immunogenic cell death immunometabolism immunomodulation immunomodulators immunotherapeutic agent immunotherapies immunotherapy lentiviral transduction lentivirus leukemia cells lung metastasis lymphoma lytic peptides macrophages melanoma microenvironment miRNA mitochondria mitochondrial transfer myeloid-derived suppressor cells n/a nanoparticles oncolytic viral therapy pathogenesis pediatric solid tumors personalized medicine programmed cell death 1 ligand 1 programmed cell death protein 1 regulatory T cells resistance risk factors solid tumors targeted therapy targeted treatment triple-negative breast cancer tuft cells tumor tumor antigen tumor antigens tumor immune evasion tumor microenvironment tumor stem cells tumor stroma tunneling nanotubes tyrosine kinase inhibitors β2 integrins |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580205403321 |
Golubovskaya Vita
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Oncolytic Virus Immunotherapy
| Oncolytic Virus Immunotherapy |
| Autore | Marchini Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
adenovirus
adoptive T cell therapy antigen-agnostic vaccination antitumor immune response arming biomarkers cancer cancer immune therapy cancer immunotherapy cancer therapy CAR T cell checkpoint inhibitor checkpoint inhibitors class I HLA clinical trials colorectal cancer combination therapy combinatory therapy CTLA-4 delivery DNA methyltransferase inhibitor (DNMTi) epigenetic silencing genetic modification glioblastoma HER2 herpes simplex virus HSV-1 immune checkpoint blockade immune checkpoint inhibitor immunoediting immunogenic cell death immunostimulatory immunosurveillance immunotherapy measles virus melanoma multi-stage n/a NDV newcastle disease virus oncogenic signaling oncolytic oncolytic adenovirus oncolytic virus oncolytic viruses pancreatic cancer pancreatic ductal adenocarcinoma parvovirus PD-1 PD-L1 personalized oncolyticvirotherapy RAS reovirus retargeted virus small molecule targeting tropism retargeting tumor tumor microenvironment type I interferon vaccination vector engineering vesicular stomatitis virus viral mimicry virotherapy αvβ6 integrin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566462203321 |
|
Marchini Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||